Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Jun 2021

Martínez-Vila Clara, Laguna Juan C, Segui Elia, Ruiz Gustavo, Aya Moreno Francisco, Fernandez-Morales Luis M, Giner Joaquim Julia, Padrosa Joan, Fernandez Laia, Gaba Lydia, Victoria Ivan, Arance Fernandez Ana M

Abstract excerpt

Since the approval of immune checkpoint anti-programmed cell death protein 1 antibodies (pembrolizumab and nivolumab) and anti-cytotoxic T-lymphocyte-associated protein 4 (ipilimumab) in combination or monotherapy, significant advances have been made in the treatment of metastatic melanoma. The nonspecific immune stimulation resulting from these drugs can case a wide range of side effects in many organs including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Disease Management

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to Encephalitis

Share to Immune Checkpoint Inhibitors

Share to Melanoma

Share to Molecular Targeted Therapy

Share to Neoplasm Grading

Source

Identifiers

PMID: 33950029
DOI: 10.1097/CJI.0000000000000369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma.PMID 33950029Read ↗

BRAF Inhibitor Therapy-Related Encephalitis in a Patient with Metastatic Melanoma.Semantic proximity Read ↗

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosisSemantic proximity Read ↗

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors.Semantic proximity Read ↗

Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report.Semantic proximity Read ↗

Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature reviewSemantic proximity Read ↗

Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.Semantic proximity Read ↗

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathiesSemantic proximity Read ↗

Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma.Semantic proximity Read ↗

Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan.Semantic proximity Read ↗

Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases.Semantic proximity Read ↗

Paraneoplastic Diseases of the Central Nervous SystemSemantic proximity Read ↗

Neurologic outcomes in people with multiple sclerosis treated with immune checkpoint inhibitors for oncologic indicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.